Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

Rory Steyn on who really runs South African sport

In two years, Comrades runners threw out a board accused of vote-buying and steering tenders to friends, and cut ties with the provincial and national athletics bodies to run their own race. Swimming South Africa had to wait for an integrity panel in Switzerland to act. Rory Steyn, Nelson Mandela's…
29 Sep 11AM 39 min

Criminals - NOT cops - patrol SA’s streets of fear… | Lisa Schickerling

In this interview Chris Steyn and Lisa Schickerling, the Democratic Alliance (DA) spokesperson on Police, talk about a country in the grip of fear in the wake of mass killings, multiple murders, crime increasing in areas where the SANDF have been deployed, and suspended Deputy National Commissioner of Police General…
28 Sep 9AM 21 min